| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/23/2009 | WO2009051078A1 Therapeutic gene expression system |
| 04/23/2009 | WO2009050743A1 Pharmaceutical composition comprising ecballium elaterium juice and their use in medical field |
| 04/23/2009 | WO2009050575A1 Inhibitors of fungal biofilm-formation |
| 04/23/2009 | WO2009050451A1 Antibacterial composition comprising salvia extracts |
| 04/23/2009 | WO2009050446A1 Viral therapeutic |
| 04/23/2009 | WO2009050390A2 Method for producing flu virus |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009049491A1 Substituted diphenylamines as inhibitors of reverse transcriptase, process of preparing them and use thereof |
| 04/23/2009 | WO2009049490A1 Use of aminoglycoside antibiotic in the preparation of pharmaceutical composition for treating drug-resistant bacterial infection |
| 04/23/2009 | WO2009049406A1 Use of ps20 /wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | WO2009049378A1 Lactone derivatives |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | WO2009030890A9 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| 04/23/2009 | WO2009023191A3 An improved process for the preparation of clarithromycin |
| 04/23/2009 | WO2009019230A3 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| 04/23/2009 | WO2009010765A3 Lantibiotic-based compounds having antimicrobial activity |
| 04/23/2009 | WO2009004322A3 Derivatives of nystatin and their use as antifungal agents |
| 04/23/2009 | WO2008138658A3 Pharmaceutical compounds comprising abasic oligonucleotides |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | WO2008117091A3 Treatments for bacterial, parasitic, fungal and prionic infections |
| 04/23/2009 | WO2008117089A3 Treatments for viral infections |
| 04/23/2009 | US20090106852 Influenza Therapeutic |
| 04/23/2009 | US20090105694 Medical or veterinary digestive tract utilization systems and methods |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105460 Antibody and inhibitor, and transfection method or kit using them |
| 04/23/2009 | US20090105337 Esters of Florfenicol |
| 04/23/2009 | US20090105302 (2-Pyrazol-1-yl-5-trifluoromethylphenyl)carbamic acid 4-cyclopropanesulfonylamino-carbonyl-13-methyl-2,14-dioxo-3,13-diazatricyclo-[13.3.0.04,6]octadec-7-en-17-yl ester; viricides; potency, decreased cytotoxicity, improved pharmacokinetics, improved resistance profile; liver disorders; ritonavir |
| 04/23/2009 | US20090105295 Hydroxylamine substituted imidazoquinolines |
| 04/23/2009 | US20090105287 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties |
| 04/23/2009 | US20090105261 Novel substituted pyrazolo[1,5<I>A</I>]-1,3,5-Triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 04/23/2009 | US20090105232 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 04/23/2009 | US20090105227 Thienopyrroles As Antiviral Agents |
| 04/23/2009 | US20090105217 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 04/23/2009 | US20090105212 Immunomoderators; antiallergens; viricides; bactericides; anticancer agents; rhinitis; hepatitis; skin disorders |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105203 Compounds for treating viral infections |
| 04/23/2009 | US20090105192 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 04/23/2009 | US20090105186 Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases |
| 04/23/2009 | US20090105185 Nucleosides with anti-hepatitis B Virus activity |
| 04/23/2009 | US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/23/2009 | US20090105147 Deuterated etravirine |
| 04/23/2009 | US20090105143 Hiv fusion inhibitor peptides with improved biological properties |
| 04/23/2009 | US20090105126 Methods of Treating Pulmonary Disorders using Liposomal Vancomycin Formulations |
| 04/23/2009 | US20090105088 Mutant bank |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104694 Isolation and transplantation of retinal stem cells |
| 04/23/2009 | US20090104662 Use of interleukin-4 antagonists and compositions thereof |
| 04/23/2009 | US20090104651 Screening process for antibacterial agents |
| 04/23/2009 | US20090104297 Herbal composition for treatment of infections caused by dermatophytes |
| 04/23/2009 | US20090104287 Protocol for AIDS prevention and treatment by nutritional methods |
| 04/23/2009 | US20090104256 Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations |
| 04/23/2009 | US20090104249 Exotoxin Inhibitory Factor |
| 04/23/2009 | US20090104237 Method for increasing tissue oxygenation |
| 04/23/2009 | US20090104233 IDENTIFICATION OF RESIDUES CRITICAL FOR THE FUNCTION OF THE VIBRIO CHOLERAE VIRULENCE REGULATOR ToxT BY SCANNING ALANINE MUTAGENESIS |
| 04/23/2009 | US20090104231 Vaccine |
| 04/23/2009 | US20090104229 Novel use |
| 04/23/2009 | US20090104224 Modified vaccinia virus ankara for the vaccination of neonates |
| 04/23/2009 | US20090104223 Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations |
| 04/23/2009 | US20090104218 Group B Streptococcus |
| 04/23/2009 | US20090104212 Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
| 04/23/2009 | US20090104209 Methods of reducing a viral infection and kits therefore |
| 04/23/2009 | US20090104205 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus |
| 04/23/2009 | US20090104204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104188 Anti-hepatitis c virus antibody and uses thereof |
| 04/23/2009 | US20090104153 Method of eliciting immune response |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104149 Compositions For HCV Treatment |
| 04/23/2009 | DE112004001191T5 Aztreonam L-Lysin und Verfahren für dessen Herstellung Aztreonam L-lysine and method for its preparation |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2701761A1 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 04/23/2009 | CA2700288A1 Method for producing flu virus |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050464A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 04/22/2009 | EP2050463A2 Vaccine compositon for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| 04/22/2009 | EP2050459A1 Prophylactic or therapeutic agent for viral disease |
| 04/22/2009 | EP2049547A2 Aza-peptide protease inhibitors |
| 04/22/2009 | EP2049540A1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
| 04/22/2009 | EP2049522A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049516A2 Pharmaceutical compounds |
| 04/22/2009 | EP2049511A1 Use of coumarin derivatives in antifungal therapy |
| 04/22/2009 | EP2049506A2 Modulators of pharmacokinetic properties of therapeutics |
| 04/22/2009 | EP2049200A2 Novel inhibitors of beta-lactamase |
| 04/22/2009 | EP2049154A1 Plasmids with immunological action |
| 04/22/2009 | EP2049142A1 Caspofungin formulations |
| 04/22/2009 | EP2049126A2 Liposome treatment of viral infections |
| 04/22/2009 | EP2049116A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049114A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049112A2 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents |
| 04/22/2009 | EP2049105A2 Anti-microbial photodynamic therapy |
| 04/22/2009 | EP2049103A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | EP1830861B1 Antiviral and immunostimulating marine fish oil composition |
| 04/22/2009 | EP1641470B1 Vaginal compositions for treating pelvic tissue infections and traumas |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1424387B1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |